Collagen i regulates matrix metalloproteinase-2 activation in osteosarcoma cells independent of S100A4

FEBS Journal

Volumn 276, Issue 18, 2009, Pages 5275-5286

  Elenjord, Renate ^a   Allen, Jasmine B ^a   Johansen, Harald T ^b   Kildalsen, Hanne ^a   Svineng, Gunbjørg ^a   Mælandsmo, Gunhild M ^a,c   Loennechen, Thrina ^a   Winberg, Jan Olof ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Collagen I; Extracellular matrix; Inhibitors of matrix metalloproteinases; Matrix metalloproteinases; S100A4

Indexed keywords

CALVASCULIN; COLLAGEN; COLLAGEN TYPE 1; FIBRILLAR COLLAGEN; GELATINASE A; MATRIX METALLOPROTEINASE 14; MONOMERIC COLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REDUCTION;

ACTINS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; COLLAGEN TYPE I; ENZYME ACTIVATION; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; OSTEOSARCOMA; S100 PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 69449103107     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07223.x     Document Type: Article

References (49)

1. Gelse K, Poschl E Aigner T (2003) Collagens - structure, function, and biosynthesis. Adv Drug Deliv Rev 55, 1531 1546.
2. Murphy G Nagase H (2008) Progress in matrix metalloproteinase research. Mol Aspects Med 29, 290 308.
3. Bjorklund M Koivunen E (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755, 37 69.
4. Chen JM, Fortunato M, Stevens RA Barrett AJ (2001) Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol Chem 382, 777 783.
5. Nie J Pei D (2003) Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the Asn(109)-Tyr bond. Cancer Res 63, 6758 6762.
6. Lafleur MA, Tester AM Thompson EW (2003) Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism. FEBS Lett 553, 457 463.
7. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW Strongin AY (2001) MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263, 209 223.
8. Borrirukwanit K, Lafleur MA, Mercuri FA, Blick T, Price JT, Fridman R, Pereira JJ, Leardkamonkarn V Thompson EW (2007) The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells. Matrix Biol 26, 291 305.
9. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB et al. (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107, 789 800.
10. Elenjord R, Ljones H, Sundkvist E, Loennechen T Winberg JO (2008) Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4. Connect Tissue Res 49, 185 188.
11. Helfman DM, Kim EJ, Lukanidin E Grigorian M (2005) The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92, 1955 1958.
12. Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Florenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ Fodstad O (1996) Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 56, 5490 5498.
13. Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O Maelandsmo GM (1999) S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 59, 4702 4708.
14. Mathisen B, Lindstad RI, Hansen J, El-Gewely SA, Maelandsmo GM, Hovig E, Fodstad O, Loennechen T Winberg JO (2003) S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis 20, 701 711.
15. Ward RV, Hembry RM, Reynolds JJ Murphy G (1991) The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J 278, 179 187.
16. DeClerck YA, Yean TD, Lu HS, Ting J Langley KE (1991) Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem 266, 3893 3899.
17. Knauper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A Tschesche H (1993) Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 295, 581 586.
18. Loennechen T, Mathisen B, Hansen J, Lindstad RI, El-Gewely SA, Andersen K, Maelandsmo GM Winberg JO (2003) Colchicine induces membrane-associated activation of matrix metalloproteinase-2 in osteosarcoma cells in an S100A4-independent manner. Biochem Pharmacol 66, 2341 2353.
19. Bratland A, Ragnhildstveit E, Bjornland K, Andersen K, Maelandsmo GM, Fodstad O, Saatcioglu F Ree AH (2003) The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells. Clin Exp Metastasis 20, 541 547.
20. Reppe S, Olstad OK, Rian E, Gautvik VT, Gautvik KM Jemtland R (2004) Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells. Biochem Biophys Res Commun 324, 218 223.
21. Azzam HS Thompson EW (1992) Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res 52, 4540 4544.
22. Takino T, Miyamori H, Watanabe Y, Yoshioka K, Seiki M Sato H (2004) Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res 64, 1044 1049.
23. Seltzer JL, Lee AY, Akers KT, Sudbeck B, Southon EA, Wayner EA Eisen AZ (1994) Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res 213, 365 374.
24. Lee AY, Akers KT, Collier M, Li L, Eisen AZ Seltzer JL (1997) Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc Natl Acad Sci USA 94, 4424 4429. (Pubitemid 27194257)
25. Zigrino P, Drescher C Mauch C (2001) Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins. Eur J Cell Biol 80, 68 77.
26. Ruangpanit N, Chan D, Holmbeck K, Birkedal-Hansen H, Polarek J, Yang C, Bateman JF Thompson EW (2001) Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form. Matrix Biol 20, 193 203.
27. Ruangpanit N, Price JT, Holmbeck K, Birkedal-Hansen H, Guenzler V, Huang X, Chan D, Bateman JF Thompson EW (2002) MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen. Exp Cell Res 272, 109 118.
28. Nguyen M, Arkell J Jackson CJ (2000) Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP. Int J Biochem Cell Biol 32, 621 631.
29. Tomasek JJ, Halliday NL, Updike DL, Ahern-Moore JS, Vu TK, Liu RW Howard EW (1997) Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 272, 7482 7487.
30. Theret N, Lehti K, Musso O Clement B (1999) MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells. Hepatology 30, 462 468.
31. Haas TL, Davis SJ Madri JA (1998) Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273, 3604 3610.
32. Guo C Piacentini L (2003) Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts. J Biol Chem 278, 46699 46708.
33. Sato K, Hattori S, Irie S Kawashima S (2003) Spike formation by fibroblasts adhering to fibrillar collagen I gel. Cell Struct Funct 28, 229 241.
34. Ispanovic E Haas TL (2006) JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 291, C579 C588.
35. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA Goldberg GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270, 5331 5338.
36. Will H, Atkinson SJ, Butler GS, Smith B Murphy G (1996) The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271, 17119 17123.
37. Winberg JO, Berg E, Kolset SO Uhlin-Hansen L (2003) Calcium-induced activation and truncation of promatrix metalloproteinase-9 linked to the core protein of chondroitin sulfate proteoglycans. Eur J Biochem 270, 3996 4007.
38. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M Nagase H (1992) Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 285, 603 611.
39. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K Hayakawa T (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267, 21712 21719.
40. Suzuki K, Kan CC, Hung W, Gehring MR, Brew K Nagase H (1998) Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli: autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1). Biol Chem 379, 185 191.
41. Duffy MJ, McGowan PM Gallagher WM (2008) Cancer invasion and metastasis: changing views. J Pathol 214, 283 293.
42. Hornebeck W, Lambert E, Petitfrere E Bernard P (2005) Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie 87, 377 383.
43. Martin MD Matrisian LM (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26, 717 724.
44. Chirco R, Liu XW, Jung KK Kim HR (2006) Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 25, 99 113.
45. Stetler-Stevenson WG (2008) Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal 1, re6.
46. Fodstad O, Brogger A, Bruland O, Solheim OP, Nesland JM Pihl A (1986) Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int J Cancer 38, 33 40.
47. Kurschat P, Zigrino P, Nischt R, Breitkopf K, Steurer P, Klein CE, Krieg T Mauch C (1999) Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem 274, 21056 21062.
48. Chen JM, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, Hewitt E, Watts C Barrett AJ (1997) Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem 272, 8090 8098.
49. Johansen HT, Knight CG Barrett AJ (1999) Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis. Anal Biochem 273, 278 283.